Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cryptococcal Meningitis
100%
Meningitis
37%
COVID-19
30%
Cerebrospinal Fluid
29%
Cryptococcal Antigen
29%
Advanced HIV Disease
26%
Amphotericin B
23%
Cryptococcal Antigenemia
22%
Hydroxychloroquine
22%
Uganda
22%
Ugandan
20%
Cytomegalovirus Viremia
20%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
18%
AIDS/HIV
17%
Cryptococcal Antigen Screening
17%
Fluconazole
16%
Randomized Clinical Trial
16%
Clinical Trials
15%
Pre-exposure Prophylaxis (PrEP)
13%
Virus Diseases
12%
Lateral Flow Assay
12%
Randomized Trial
12%
HIV-associated
12%
C-reactive Protein
12%
Cryptococcosis
11%
Sub-Saharan Africa
11%
95% Confidence Interval
11%
Mycobacterium Tuberculosis (M. tb)
11%
Cryptococcal Antigen Titer
10%
Cryptococcus
10%
Persons with HIV
10%
Amphotericin B Deoxycholate
10%
Early Fungicidal Activity
10%
HIV-associated Cryptococcal Meningitis
10%
Lamb
10%
Tuberculosis Diagnosis
9%
Flucytosine
9%
Cytomegalovirus
8%
Screening Program
8%
Risk Factors
8%
Cryptococcal Infection
8%
HIV-infected Patients
8%
Meningitis Diagnosis
8%
HIV-infected Adults
8%
Central Nervous System
8%
Serum Cryptococcal Antigen
8%
Xpert MTB/RIF Assay
8%
Placebo
7%
Adverse Events
7%
Minimum Inhibitory Concentration
7%
Immunology and Microbiology
Meningitis
77%
Human Immunodeficiency Virus
53%
Cerebrospinal Fluid
27%
Antigen
19%
COVID-19
18%
Cytomegalovirus
16%
Viremia
16%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Virus Infection
13%
C-Reactive Protein
12%
Titer
11%
Fungicidal Activity
10%
Infectious Disease
8%
Infection
8%
Deoxycholic Acid
8%
Hydroxychloroquine
8%
Lateral Flow Assay
8%
Nanocrystal
6%
Filobasidiella
6%
Blood Plasma
6%
Immune Response
5%
Cytokine
5%
Cell Function
5%
Medicine and Dentistry
Human Immunodeficiency Virus
54%
Cryptococcal Meningitis
42%
Antigen
31%
COVID-19
22%
Diseases
20%
Outpatient
20%
Meningitis
19%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Tuberculosis
13%
Virus Infection
12%
Lateral Flow Assay
11%
Hydroxychloroquine
10%
Infection
9%
Clinical Trial
9%
Cytomegalovirus
8%
Viremia
8%
Post-Exposure Prophylaxis
8%
Screening Program
6%
Etiology
6%
Cerebrospinal Fluid
5%
Randomized Clinical Trials
5%
Health Care Personnel
5%